Literature DB >> 23726850

Factors influencing haemorrhagic transformation in ischaemic stroke.

José Álvarez-Sabín1, Olga Maisterra, Estevo Santamarina, Carlos S Kase.   

Abstract

Haemorrhagic transformation (HT) of ischaemic infarction occurs when an area of brain infarction is stained with blood products, mainly red blood cells. An abnormally permeable blood-brain barrier resulting from ischaemia of the capillary endothelium allows this extravasation of blood products. HT is part of the natural history of some forms of ischaemic infarction, especially cerebral embolism, but it can be precipitated or enhanced by therapeutic interventions used in the acute phase of ischaemic stroke. The old view of HT after cerebral embolism as a generally asymptomatic change in a tissue that is already necrotic has been challenged by observations from therapeutic thrombolysis that suggest that HT can have a negative effect on patients' outcomes. Understanding of the risk factors for and the underlying mechanisms and clinical variability of HT in the context of acute therapeutic interventions in ischaemic stroke could help in the early detection of this complication, in determining the safety of recanalisation approaches, and in setting the stage for future research into the prevention or treatment of HT in patients with acute ischaemic stroke.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23726850     DOI: 10.1016/S1474-4422(13)70055-3

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  61 in total

1.  Successful use of Alteplase during cardiopulmonary resuscitation following massive PE in a patient presenting with ischaemic stroke and haemorrhagic transformation.

Authors:  Robert Middleton; Juliane Neumann; Simon Michael Ward
Journal:  BMJ Case Rep       Date:  2014-10-31

Review 2.  Simultaneous acute cardio-cerebral infarction: is there a consensus for management?

Authors:  Oluwaseun A Akinseye; Muhammad Shahreyar; Mark R Heckle; Rami N Khouzam
Journal:  Ann Transl Med       Date:  2018-01

Review 3.  Citicoline in addictive disorders: a review of the literature.

Authors:  Nicholas D Wignall; E Sherwood Brown
Journal:  Am J Drug Alcohol Abuse       Date:  2014-06-20       Impact factor: 3.829

4.  Early introduction of direct oral anticoagulants in cardioembolic stroke patients with non-valvular atrial fibrillation.

Authors:  Manuel Cappellari; Monica Carletti; Alessandra Danese; Paolo Bovi
Journal:  J Thromb Thrombolysis       Date:  2016-10       Impact factor: 2.300

5.  Systolic Blood Pressure Variability is Associated with Severe Hemorrhagic Transformation in the Early Stage After Thrombolysis.

Authors:  Keqin Liu; Shenqiang Yan; Sheng Zhang; Yang Guo; Min Lou
Journal:  Transl Stroke Res       Date:  2016-02-19       Impact factor: 6.829

6.  Cohort-Based Identification of Predictors of Symptomatic Intracerebral Hemorrhage After IV Thrombolysis.

Authors:  David Asuzu; Karin Nyström; Hardik Amin; Joseph Schindler; Charles Wira; David Greer; Nai Fang Chi; Janet Halliday; Kevin N Sheth
Journal:  Neurocrit Care       Date:  2015-12       Impact factor: 3.210

7.  Combination of the Immune Modulator Fingolimod With Alteplase in Acute Ischemic Stroke: A Pilot Trial.

Authors:  Zilong Zhu; Ying Fu; Decai Tian; Na Sun; Wei Han; Guoqiang Chang; Yinhua Dong; Xiaolin Xu; Qiang Liu; Deren Huang; Fu-Dong Shi
Journal:  Circulation       Date:  2015-07-22       Impact factor: 29.690

8.  Activation of the ACE2/Ang-(1-7)/Mas pathway reduces oxygen-glucose deprivation-induced tissue swelling, ROS production, and cell death in mouse brain with angiotensin II overproduction.

Authors:  J Zheng; G Li; S Chen; J Bihl; J Buck; Y Zhu; H Xia; E Lazartigues; Y Chen; J E Olson
Journal:  Neuroscience       Date:  2014-05-09       Impact factor: 3.590

Review 9.  [Direct oral anticoagulants and acute stroke : Insights into translational research studies].

Authors:  C Foerch; J H Schäfer; W Pfeilschifter; F Bohmann
Journal:  Nervenarzt       Date:  2017-06       Impact factor: 1.214

10.  Anticoagulation Type and Early Recurrence in Cardioembolic Stroke: The IAC Study.

Authors:  Shadi Yaghi; Eva Mistry; Ava L Liberman; James Giles; Syed Daniyal Asad; Angela Liu; Muhammad Nagy; Ashutosh Kaushal; Idrees Azher; Brian Mac Grory; Hiba Fakhri; Kiersten Brown Espaillat; Hemanth Pasupuleti; Heather Martin; Jose Tan; Manivannan Veerasamy; Charles Esenwa; Natalie Cheng; Khadean Moncrieffe; Iman Moeini-Naghani; Mithilesh Siddu; Erica Scher; Tushar Trivedi; Aaron Lord; Karen Furie; Salah Keyrouz; Amre Nouh; Christopher R Leon Guerrero; Adam de Havenon; Muhib Khan; Nils Henninger
Journal:  Stroke       Date:  2020-08-06       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.